These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Alcohol, sleep and cerebrospinal fluid changes in alcoholics: cyclic AMP and biogenic amine metabolites in CSF. Zarcone V; Schreier L; Barchas J; Orenberg E; Benson K Adv Exp Med Biol; 1977; 85A():593-9. PubMed ID: 200121 [TBL] [Abstract][Full Text] [Related]
5. Relationship between cortisol and serotonin metabolites and transporters in alcoholism [correction of alcolholism]. Heinz A; Jones DW; Bissette G; Hommer D; Ragan P; Knable M; Wellek S; Linnoila M; Weinberger DR Pharmacopsychiatry; 2002 Jul; 35(4):127-34. PubMed ID: 12163982 [TBL] [Abstract][Full Text] [Related]
6. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity? Scheinin M Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215 [TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid monoamine metabolites in alcoholic patients who attempt suicide. Roy A; Lamparski D; De Jong J; Adinoff B; Ravitz B; George DT; Nutt D; Linnoila M Acta Psychiatr Scand; 1990 Jan; 81(1):58-61. PubMed ID: 1691893 [TBL] [Abstract][Full Text] [Related]
10. Monoamine metabolites in cerebrospinal fluid and serotonin uptake inhibition during treatment with chlorimipramine. Asberg M; Ringberger VA; Sjöqvist F; Thorén P; Träskman L; Tuck JR Clin Pharmacol Ther; 1977 Feb; 21(2):201-7. PubMed ID: 13959 [TBL] [Abstract][Full Text] [Related]
11. Correlations between height of subject and concentrations of monoamine metabolites in cerebrospinal fluid from psychotic men and women. Wode-Helgodt B; Sedvall G Commun Psychopharmacol; 1978; 2(2):177-83. PubMed ID: 668302 [No Abstract] [Full Text] [Related]
12. Changes on recovery in the concentrations of tryptophan and the biogenic amine metabolites in the cerebrospinal fluid of patients with affective illness. Ashcroft GW; Blackburn IM; Eccleston D; Glen AI; Hartley W; Kinloch NE; Lonergan M; Murray LG; Pullar IA Psychol Med; 1973 Aug; 3(3):319-25. PubMed ID: 4147078 [No Abstract] [Full Text] [Related]
13. [Concentrations of monoamines and monoamine metabolites in cerebrospinal fluid determined by high-performance liquid chromatography with electrochemical detection]. Yoshino K No To Shinkei; 1982 Nov; 34(11):1099-106. PubMed ID: 6186264 [TBL] [Abstract][Full Text] [Related]
14. Monoamine related functional gene variants and relationships to monoamine metabolite concentrations in CSF of healthy volunteers. Jönsson EG; Bah J; Melke J; Abou Jamra R; Schumacher J; Westberg L; Ivo R; Cichon S; Propping P; Nöthen MM; Eriksson E; Sedvall GC BMC Psychiatry; 2004 Mar; 4():4. PubMed ID: 15102340 [TBL] [Abstract][Full Text] [Related]
15. Relationship of age and mood to monoamine metabolites in cerebrospinal fluid in parkinsonism. Granerus AK; Magnusson T; Roos BE; Svanborg A Eur J Clin Pharmacol; 1974; 7(2):105-9. PubMed ID: 4854088 [No Abstract] [Full Text] [Related]
16. Effect of age on cerebrospinal fluid levels of metabolites of biopterin and biogenic amines. Komori H; Matsuishi T; Yamada S; Ueda N; Yamashita Y; Kato H Acta Paediatr; 1999 Dec; 88(12):1344-7. PubMed ID: 10626519 [TBL] [Abstract][Full Text] [Related]
17. Developmental variations in CSF monoamine metabolites during childhood. Hedner J; Lundell KH; Breese GR; Mueller RA; Hedner T Biol Neonate; 1986; 49(4):190-7. PubMed ID: 2423144 [TBL] [Abstract][Full Text] [Related]
18. Biogenic amine metabolites in cerebrospinal fluid of patients with affective disorders. Vestergaard P; Sørensen T; Hoppe E; Rafaelsen OJ; Yates CM; Nicolaou N Acta Psychiatr Scand; 1978 Jul; 58(1):88-96. PubMed ID: 696380 [No Abstract] [Full Text] [Related]